rs779568581
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000507126.3(SRP72):n.1441A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 152,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Consequence
SRP72
ENST00000507126.3 non_coding_transcript_exon
ENST00000507126.3 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.842
Publications
0 publications found
Genes affected
SRP72 (HGNC:11303): (signal recognition particle 72) This gene encodes the 72 kDa subunit of the signal recognition particle (SRP), a ribonucleoprotein complex that mediates the targeting of secretory proteins to the endoplasmic reticulum (ER). The SRP complex consists of a 7S RNA and 6 protein subunits: SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72, that are bound to the 7S RNA as monomers or heterodimers. SRP has at least 3 distinct functions that can be associated with the protein subunits: signal recognition, translational arrest, and ER membrane targeting by interaction with the docking protein. Mutations in this gene are associated with familial bone marrow failure. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
SRP72 Gene-Disease associations (from GenCC):
- autosomal dominant aplasia and myelodysplasiaInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- acute myeloid leukemiaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BS2
High AC in GnomAd4 at 18 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SRP72 | NM_006947.4 | c.*1018A>G | 3_prime_UTR_variant | Exon 19 of 19 | ENST00000642900.1 | NP_008878.3 | ||
| SRP72 | NR_151856.2 | n.3167A>G | non_coding_transcript_exon_variant | Exon 20 of 20 | ||||
| SRP72 | NM_001267722.2 | c.*1018A>G | 3_prime_UTR_variant | Exon 17 of 17 | NP_001254651.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SRP72 | ENST00000507126.3 | n.1441A>G | non_coding_transcript_exon_variant | Exon 2 of 2 | 1 | |||||
| SRP72 | ENST00000642900.1 | c.*1018A>G | 3_prime_UTR_variant | Exon 19 of 19 | NM_006947.4 | ENSP00000495128.1 | ||||
| ENSG00000289393 | ENST00000737350.1 | n.133-25108T>C | intron_variant | Intron 1 of 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152162Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome AF: 0.000118 AC: 18AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74336 show subpopulations
GnomAD4 genome
AF:
AC:
18
AN:
152162
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74336
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41444
American (AMR)
AF:
AC:
8
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5194
South Asian (SAS)
AF:
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
4
AN:
68014
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Feb 26, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.